The global gene synthesis market is poised for extraordinary expansion, with its valuation projected to grow from USD 779.4 million in 2023 to over USD 4.5 billion by 2033. This remarkable growth corresponds to a compound annual growth rate (CAGR) of 19.2%, reflecting the increasing adoption of gene synthesis technologies across research, biotechnology, and healthcare industries.
Gene synthesis has become a cornerstone of genetic engineering, enabling researchers to create tailor-made DNA sequences for applications in therapeutics, diagnostics, and industrial biotechnology. The market’s robust growth is fueled by advancements in synthetic biology, increasing investments in gene therapy research, and the rising demand for personalized medicine.
Emerging fields such as CRISPR-based genome editing, synthetic biology tools, and vaccine development are driving innovation and expanding the applications of gene synthesis. Additionally, the growing focus on precision medicine and biopharmaceutical production is further accelerating market adoption.
As the market evolves, leading players are focusing on automating gene synthesis processes and improving turnaround times to cater to rising demand. With its pivotal role in advancing scientific discovery and healthcare innovation, the gene synthesis market is set to transform the landscape of biotechnology and personalized treatment options globally.
Key factors supporting the market growth are:
- Policies set by governments related to synthetic biology, which supports artificial gene synthesis
- Growth in life science research further reflects the development of innovative products and services
- Increasing research and development investments to meet the growing healthcare industry’s needs to combat new diseases
Key Players assist Gene Therapy Companies leverage their Capabilities
The companies operating in the gene synthesis market are expanding their single-guide RNA manufacturing capabilities. This would certainly enable next-generation gene and cell therapy research and development programs to advance their clinical trials. In December 2022, cell and gene therapy companies leveraged GenScript’s cGMP and sgRNA capability to accelerate speed.
Key developments in the market are:
- In September 2022, GenScript and Avectas collaborated to improve the non-viral cell therapy manufacturing process.
- In January 2023, Twist Bioscience and Astellas entered into a multitarget antibody discovery research collaboration.
Key Growth Drivers
- Advancements in Genetic Engineering: The ability to synthesize entire genes and metabolic pathways has significantly evolved, enhancing capabilities in genetic research and therapeutic developments.
- Increasing Demand for Personalized Medicine: As the focus on personalized treatments grows, the need for custom gene synthesis services is rising, particularly in fields like immunology and cancer research.
- Regulatory Support: Growing acceptance and authorization of synthetic gene products by regulatory bodies are facilitating market expansion.
A Detailed Full Report
Gene Synthesis Market Segmentation
By Service:
- Gene Synthesis Service (Standard Gene Service, Express Gene Service, Complex Gene Service, Custom Gene Synthesis Service)
- Gene Fragments Service
- GMP Gene Synthesis
- Others
By Application:
- Diagnostics
- Therapeutics
- Research and Development Activities
- Others
By End User:
- Academic and Research Institutes
- Biotechnology Companies
- Pharmaceutical Companies
- Contract Research Organization
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
